Dimensional Fund Advisors LP Cytek Biosciences, Inc. Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
A detailed history of Dimensional Fund Advisors LP transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,830,432 shares of CTKB stock, worth $9.37 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,830,432
Previous 1,567,825
16.75%
Holding current value
$9.37 Million
Previous $8.69 Million
36.78%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CTKB
# of Institutions
150Shares Held
74MCall Options Held
1KPut Options Held
0-
Black Rock Inc. New York, NY17.1MShares$87.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$60 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD8.25MShares$42.2 Million1.27% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$34.1 Million1.65% of portfolio
-
State Street Corp Boston, MA4.51MShares$23.1 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $689M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...